Item 3
Chief Executive’s Report
Produced by:
John Pelly, Chief Executive
Trust Board
18 December 2014
1
MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST
BOARD MEETING – 18 December 2014
Chief Executive’s Report
1. Matters considered by the Trust Management Board (TMB)
TMB held an Awayday in November in place of its usual meeting. Four key areas were
discussed as follows:
a. Moorfields Way: TMB received a detailed briefing about the outcomes of the
consultation about the Moorfields Way, the messages arising and the next steps. This
briefing was similar to the one the Board received at its strategy meeting on 20
November.
b. Transformation: Mary Sherry consulted TMB about the plans for the next steps for
transformation. Further work is required to articulate the different components and to
consolidate this into a full programme.
c. Clinical leadership structure: TMB reviewed the benefits and areas for improvement
of the current clinical leadership and management structure, following its establishment
in April 2012.
d. Multisite review: TMB discussed the key issues facing Moorfields as a single specialty
Trust offering services across multiple sites, with a particular focus on urgent and
emergency care.
2. Matters considered by the Management Executive (ME)
Three meetings of ME have taken place since my last report to the Board. The main matters
discussed are set out below:
a. Financial outlook and annual planning and budget setting processes for 2015/16:
Charles Nall and Steve Davies led a discussion about the steps needed to secure our
financial position this year, and briefed ME about the financial challenge facing us in
2015/16, the latter reflecting the latest tariff information recently published by Monitor.
Charles and Steve will say more about this at the Board meeting.
b. Next Moorfields Stars event: Rebecca Kingdom-Kruszewski briefed ME about the plans
for the next Moorfields Stars awards taking place on the afternoon and early evening of
the 18 March 2015.
c. World AIDS day, 1 December: ME confirmed its commitment to an ‘HIV no stigma’ day
on 1 December which included placing the ‘HIV no stigma’ logo on the Trust’s website.
Declan Flanagan advised ME that prior to the development of better drug treatments some
patients had gone blind as a result of HIV infection.
d. Project manager for ocular oncology: ME discussed the appointment of a project
manager to oversee the transfer of lead provision for ocular oncology services from Barts
Health to Moorfields next year.
e. Moorfields Eye Charity ‘Eye to Eye’ event, 22 March 2015: ME was reminded of this
event and members encouraged to participate if possible. It was noted that some
members of ME had already put themselves forward.
2
f.
RTT18: Mary Sherry updated ME about progress towards meeting the RTT18 targets. She
will brief the Board further on this under item 4a.
g. Theatres refurbishment: Mary Sherry and her team continue to develop plans for this
complex project. By the time of the Board meeting, TMB will have discussed the plans and
she will brief the Board about the outcomes of that discussion under item 4a.
h. Latest version of the CQC intelligent monitoring tool: ME noted that Moorfields’
priority for inspection rating, as determined by CQC using their ‘intelligent monitoring tool’,
had worsened from six to four, six being the lowest priority for inspection. This
deterioration had come about as a result of the outcomes of the latest A&E patient survey
(of patients who had visited the hospital in February and March 2014). Although the
overall picture was good, patient responses to two of the questions - one asking about
how long they had to wait before being examined and one asking about whether staff did
everything they could to help control pain – were relatively poor. Ian Tombleson and Tracy
Luckett have been liaising with the CQC about the outcome of the survey and its impact
on the Trust’s rating and I will ask them to brief the Board further.
i.
Fit and proper persons test and duty of candour: Sally Storey briefed ME about the
new obligations for directors arising from the ‘fit and proper persons test’ that came into
force on 1 October 2014. She will be issuing a questionnaire to all directors shortly, which
will enable us to demonstrate that all directors meet the fit and proper persons test
requirements. All future director level appointments will also need to take account of these
requirements. Ian Tombleson will brief the Board in January about the Trust’s compliance
with the new duty of candour, which also came into force on 1 October.
3. Other matters of note
a.
Chancellor’s Autumn Statement: The Chancellor issued his Autumn Statement on 3
December and I attach a briefing note from NHS Providers (the FTN rebranded itself from
1 December with its remit now covering all NHS providers rather than just FTs) that
summarises the key messages for the NHS. Charles will say more about this at the Board
if required.
b.
Publication of Sir David Dalton’s review of NHS providers: Sir David published his
long awaited review on 5 December and I will ask Rob Elek to brief the Board orally about
its main outcomes.
c.
Ghana: Ian Murdoch, Charles Nall and I visited Ghana last month and I will provide a brief
oral summary of progress with this project at the Board meeting.
4. Senior appointments and departures
There have been no senior appointments or departures since my last report to the Board.
John Pelly
Chief Executive
3